Treatment of the terminal titanium–phosphinidene (Nacnac)TiPMes*(CH2tBu) (Nacnac− = [2,6-iPr2C6H3]–NC(CH3)CHC(CH3)N[2,6-iPr2C6H3], Mes*− = 2,4,6-tBu3C6H2) with CNtBu and N2CPh2, in pentane at −35 °C, affords η2-(N,C)-phosphaazaallene and phosphinylimide complexes, respectively.
No takes yet. Share an insight, caveat, or question.
Basuli et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: